• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氮杂芳族季铵类似物:神经元烟碱受体α4β2*和α7*亚型的配体。

bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.

作者信息

Ayers Joshua T, Dwoskin Linda P, Deaciuc A Gabriela, Grinevich Vladimir P, Zhu Jun, Crooks Peter A

机构信息

Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.

出版信息

Bioorg Med Chem Lett. 2002 Nov 4;12(21):3067-71. doi: 10.1016/s0960-894x(02)00687-x.

DOI:10.1016/s0960-894x(02)00687-x
PMID:12372503
Abstract

A series of bis-nicotinium, bis-pyridinium, bis-picolinium, bis-quinolinium and bis-isoquinolinium compounds was evaluated for their binding affinity at nicotinic acetylcholine receptors (nAChRs) using rat brain membranes. N,N'-Decane-1,12-diyl-bis-nicotinium diiodide (bNDI) exhibited the highest affinity for [(3)H]nicotine binding sites (K(i)=330 nM), but did not inhibit [(3)H]methyllycaconitine binding (K(i) >100 microM), indicative of an interaction with alpha4beta2*, but not alpha7* receptor subtypes, respectively. Also, bNDI inhibited (IC(50)=3.76 microM) nicotine-evoked (86)Rb(+) efflux from rat thalamic synaptosomes, indicating antagonist activity at alpha4beta2* nAChRs. N,N'-Dodecane-1,12-diyl-bis-quinolinium dibromide (bQDDB) exhibited highest affinity for [(3)H]methyllycaconitine binding sites (K(i)=1.61 microM), but did not inhibit [(3)H]nicotine binding (K(i)>100 microM), demonstrating an interaction with alpha7*, but not alpha4beta2* nAChRs. Thus, variation of N-n-alkyl chain length together with structural modification of the azaaromatic quaternary ammonium moiety afforded selective antagonists for the alpha4beta2* nAChR subtype, as well as ligands with selectivity at alpha7* nAChRs.

摘要

使用大鼠脑膜评估了一系列双烟碱鎓、双吡啶鎓、双皮考啉鎓、双喹啉鎓和双异喹啉鎓化合物对烟碱型乙酰胆碱受体(nAChRs)的结合亲和力。N,N'-癸烷-1,12-二基-双烟碱鎓二碘化物(bNDI)对[(3)H]尼古丁结合位点表现出最高亲和力(K(i)=330 nM),但不抑制[(3)H]甲基番木鳖碱结合(K(i)>100 microM),分别表明其与α4β2而非α7受体亚型相互作用。此外,bNDI抑制(IC(50)=3.76 microM)尼古丁诱发的大鼠丘脑突触体中(86)Rb(+)外流,表明其对α4β2* nAChRs具有拮抗剂活性。N,N'-十二烷-1,12-二基-双喹啉鎓二溴化物(bQDDB)对[(3)H]甲基番木鳖碱结合位点表现出最高亲和力(K(i)=1.61 microM),但不抑制[(3)H]尼古丁结合(K(i)>100 microM),证明其与α7而非α4β2 nAChRs相互作用。因此,N-正烷基链长度的变化以及氮杂芳族季铵部分的结构修饰提供了α4β2* nAChR亚型的选择性拮抗剂以及对α7* nAChRs具有选择性的配体。

相似文献

1
bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.双氮杂芳族季铵类似物:神经元烟碱受体α4β2*和α7*亚型的配体。
Bioorg Med Chem Lett. 2002 Nov 4;12(21):3067-71. doi: 10.1016/s0960-894x(02)00687-x.
2
Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.将不饱和键引入烟碱受体拮抗剂NONI和NDNI的N-正烷基链中:对亲和力和选择性的影响。
AAPS J. 2005 Aug 29;7(1):E201-17. doi: 10.1208/aapsj070119.
3
Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.双芳基季铵盐作为介导尼古丁诱发多巴胺释放的烟碱受体拮抗剂:结合构象研究
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6734-8. doi: 10.1016/j.bmcl.2007.10.052. Epub 2007 Oct 18.
4
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.N-正烷基烟碱类似物,一类新型烟碱受体拮抗剂:与α4β2*和α7*神经元烟碱受体的相互作用。
J Pharmacol Exp Ther. 2003 Jan;304(1):400-10. doi: 10.1124/jpet.102.043349.
5
Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.三氮杂芳族季铵盐:作为烟碱受体拮抗剂的新型模板,介导尼古丁诱发的多巴胺释放。
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6701-6. doi: 10.1016/j.bmcl.2007.10.062. Epub 2007 Oct 22.
6
N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes.N-正烷基烟碱类似物,一类新型的α4β2*烟碱型乙酰胆碱受体拮抗剂:对S(-)-尼古丁诱发的大鼠丘脑突触体86Rb+外流的抑制作用。
AAPS J. 2006 Jan 13;7(4):E922-30. doi: 10.1208/aapsj070490.
7
N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.N-正烷基吡啶类似物,一类新型烟碱受体拮抗剂:对尼古丁诱发的[3H]多巴胺从灌流大鼠纹状体切片中溢出的选择性抑制。
J Pharmacol Exp Ther. 2003 Sep;306(3):1011-20. doi: 10.1124/jpet.103.051789. Epub 2003 May 23.
8
r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.r-bPiDI,一种α6β2*烟碱型受体拮抗剂,可减少尼古丁诱发的多巴胺释放和尼古丁强化作用。
Neurochem Res. 2015 Oct;40(10):2121-30. doi: 10.1007/s11064-015-1680-4. Epub 2015 Jul 31.
9
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.甲基lycaconitine是大鼠纹状体中α-芋螺毒素-MII敏感的突触前烟碱型乙酰胆碱受体的强效拮抗剂。
J Pharmacol Exp Ther. 2002 Jul;302(1):197-204. doi: 10.1124/jpet.302.1.197.
10
Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists.新型三氮杂和四氮杂芳族季铵拮抗剂对α7神经元烟碱型乙酰胆碱受体乙酰胆碱诱发反应的选择性抑制作用
Mol Pharmacol. 2009 Sep;76(3):652-66. doi: 10.1124/mol.109.056176. Epub 2009 Jun 25.

引用本文的文献

1
Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents.用于预测烟草成分与人烟碱型乙酰胆碱受体α7结合的竞争性对接模型。
Oncotarget. 2018 Feb 8;9(24):16899-16916. doi: 10.18632/oncotarget.24458. eCollection 2018 Mar 30.
2
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.药理学上不同的烟碱型乙酰胆碱受体在前庭萼状传入神经中驱动传出介导的兴奋。
J Neurosci. 2015 Feb 25;35(8):3625-43. doi: 10.1523/JNEUROSCI.3388-14.2015.
3
Nicotinic receptor antagonists as treatments for nicotine abuse.
烟碱受体拮抗剂作为尼古丁成瘾的治疗方法。
Adv Pharmacol. 2014;69:513-51. doi: 10.1016/B978-0-12-420118-7.00013-5.
4
Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.新型小分子α9α10 烟碱型乙酰胆碱受体拮抗剂预防和逆转大鼠化疗诱发的神经性疼痛。
Anesth Analg. 2012 Sep;115(3):713-20. doi: 10.1213/ANE.0b013e31825a3c72. Epub 2012 May 18.
5
Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.发现非肽小分子α9α10 型烟碱型乙酰胆碱受体拮抗剂作为新型镇痛药治疗神经性和紧张性炎症性疼痛。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2476-9. doi: 10.1016/j.bmcl.2011.02.043. Epub 2011 Feb 23.
6
bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.bPiDI:一种新型选择性α6β2*烟碱型乙酰胆碱受体拮抗剂,也是用于治疗尼古丁滥用的临床前候选药物。
Br J Pharmacol. 2011 May;163(2):346-57. doi: 10.1111/j.1476-5381.2011.01220.x.
7
Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.新型双、三、四取代叔氨基类似物作为神经元烟碱型受体拮抗剂,可介导尼古丁诱导的多巴胺释放。
Bioorg Med Chem Lett. 2011 Jan 1;21(1):88-91. doi: 10.1016/j.bmcl.2010.11.070. Epub 2010 Nov 24.
8
Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.双芳基季铵盐作为血脑屏障胆碱转运体的配体。
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3208-10. doi: 10.1016/j.bmcl.2010.04.098. Epub 2010 Apr 24.
9
Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.反复给予尼古丁可显著增强含 alpha6beta2 的烟碱型乙酰胆碱受体介导的尼古丁诱导的多巴胺释放中 bPiDDB 的抑制效力。
Biochem Pharmacol. 2010 Aug 1;80(3):402-9. doi: 10.1016/j.bcp.2010.03.018. Epub 2010 Mar 25.
10
Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.血脑屏障胆碱转运体潜在阳离子载体介导转运的预测筛选模型。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):870-7. doi: 10.1016/j.bmcl.2009.12.079. Epub 2009 Dec 28.